The 13-1 vote follows FDA approval for a booster dose in that age group on Monday. The committee backed a “should” rather than a “may” recommendation for ages 12-15 and for ages 16-17 as well.
from WebMD Health https://www.webmd.com/vaccines/covid-19-vaccine/news/20220105/cdc-panel-backs-pfizer-boosters?src=RSS_PUBLIC
0 Comments:
Post a Comment